SCHEMBL2845824

SCHEMBL2845824

CCCCCC(N)N(CC)CC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.50
PLA2G1B P04054 1/20 0.48
PLA2G2A P14555 1/20 0.48
SPHK1 Q9NYA1 2/20 0.41
TP53 P04637 2/20 0.40
LAP3 P28838 2/20 0.40
CYP2D6 P10635 2/20 0.39
LMNA P02545 2/20 0.39
GMNN O75496 1/20 0.39
POLB P06746 1/20 0.39
THPO P40225 1/20 0.39
MTOR P42345 1/20 0.39
BLM P54132 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
CETP P11597 1/20 0.39
HTT P42858 1/20 0.39
UBE2N P61088 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8751118 0.98 PLA2G1B (0.52) OPRM1PLA2G1BPLA2G2ASPHK1TP53
SCHEMBL20678370 0.98 PLA2G1B (0.52) OPRM1PLA2G1BPLA2G2ASPHK1TP53
SCHEMBL18315357 0.98 PLA2G1B (0.52) OPRM1PLA2G1BPLA2G2ASPHK1TP53
SCHEMBL1396281 0.92 OPRM1 (0.40) OPRM1PLA2G1BPLA2G2ASPHK1TP53
SCHEMBL10879073 0.83 OPRM1 (0.48) OPRM1PLA2G1BPLA2G2ASPHK1TP53
SCHEMBL7189754 0.83 OPRM1 (0.48) OPRM1PLA2G1BPLA2G2ASPHK1TP53
SCHEMBL27863177 0.83 GSR (0.37) OPRM1PLA2G1BPLA2G2A
SCHEMBL187299 0.81 PLA2G1B (0.33) OPRM1PLA2G1BPLA2G2A
SCHEMBL6908178 0.81 PLA2G1B (0.50) OPRM1PLA2G1BPLA2G2ASPHK1TP53
SCHEMBL15477624 0.81 PLA2G1B (0.50) OPRM1PLA2G1BPLA2G2ASPHK1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2764860-A1 Cupuassu fatty acid amidoamines and their derivatives BASF SA (BR) 2014-08-13 EP claimed
EP-1092737-B1 Catalyst composition for the production of a polyurethane resin, and method for producing a polyurethane resin TOSOH CORP (JP) 2003-09-24 EP claimed
US-6596663-B1 Reacting a polyol with an organic polyisocyanate in the presence of a diamine catalyst and, if necessary, a blowing agent, a surfactant, a cross-linking agent TOSOH CORPORATION (JP) 2003-07-22 US claimed
EP-1092737-A2 Catalyst composition for the production of a polyurethane resin, and method for producing a polyurethane resin Tosoh Corporation (JP) 2001-04-18 EP claimed
CN-107540565-B Preparation of N, N- (di) alkylaminoalkyl (meth) acrylamides or the corresponding esters and quaternary ammonium salts thereof 赢创运营有限公司 2022-10-21 CN disclosed
US-10343980-B2 Preparation of N,N-(di)alkylaminoalkyl(meth)acrylamide or N,N-(di)alkylaminoalkyl (meth)acrylate and the quaternary ammonium salts thereof as flocculating aids and gelling agents EVONIK ROEHM GMBH (DE) 2019-07-09 US disclosed
US-20170369424-A1 PREPARATION OF N,N-(DI)ALKYLAMINOALKYL(METH)ACRYLAMIDE OR N,N-(DI)ALKYLAMINOALKYL (METH)ACRYLATE AND THE QUATERNARY AMMONIUM SALTS THEREOF AS FLOCCULATING AIDS AND GELLING AGENTS EVONIK ROEHM GMBH (DE) 2017-12-28 US disclosed
US-20170174800-A1 Partially Quaternized Styrene-Based Copolymer, Ionic-Conductivity Imparter, Catalytic Electrode Layer, Membrane/Electrode Assembly and Process for Producing Same, Gas Diffusion Electrode and Process for Producing Same, and Fuel Cell of Anion Exchange Membrane Type TOKUYAMA CORPORATION (JP) 2017-06-22 US disclosed
EP-3106476-A1 PARTIALLY QUATERNIZED STYRENE-BASED COPOLYMER, IONIC-CONDUCTIVITY IMPARTER, CATALYTIC ELECTRODE LAYER, MEMBRANE/ELECTRODE ASSEMBLY AND PROCESS FOR PRODUCING SAME, GAS DIFFUSION ELECTRODE AND PROCESS FOR PRODUCING SAME, AND FUEL CELL OF ANION EXCHANGE MEMBRANE TYPE Tokuyama Corporation (JP) 2016-12-21 EP disclosed
US-8877825-B2 Catalyst composition for production of polyurethane resin and method for producing polyurethane resin TOSOH CORPORATION (JP) 2014-11-04 US disclosed
EP-2764860-A1 Cupuassu fatty acid amidoamines and their derivatives BASF SA (BR) 2014-08-13 EP disclosed
EP-2092021-B1 PIGMENT DISPERSANTS SUN CHEMICAL CORP (US) 2014-05-21 EP disclosed
US-20010025124-A1 Dissolving 3-butene-1,2-diol in alkanol; ozonolysis AKZO NOBEL N.V. (NL) 2001-09-27 US disclosed
WO-2001062696-A1 PROCESS FOR THE PREPARATION OF GLYCERALDEHYDE AND DERIVATIVES THEREOF AKZO NOBEL N.V. (NL) 2001-08-30 WO disclosed
WO-2001055229-A1 PROCESS TO MAKE AMINATED POLYOLEFINS AKZO NOBEL N.V. (NL) 2001-08-02 WO disclosed
US-20010008912-A1 Pigment dispersants based on diketopyrrolopyrrole compounds and pigment preparations CLARIANT GMBH 2001-07-19 US disclosed
EP-1092737-A2 Catalyst composition for the production of a polyurethane resin, and method for producing a polyurethane resin Tosoh Corporation (JP) 2001-04-18 EP disclosed
US-5958129-A SPECIFIC ORGANIC PIGMENTS AND A PIGMENT DISPERSING AGENT COMPRISING AN ANTHRA(2,1,9-DEF:6,5,10)DIISOQUINOLINE DERIVATIVE; IMPROVED RHEOLOGICAL AND COLORING PROPERTIES, FOR PIGMENTING HIGH MOLECULAR WEIGHT ORGANIC MATERIALS CLARIANT GMBH (DE) 1999-09-28 US disclosed
EP-0389079-B1 Polyamides bearing functionalized side chains useful as water soluble hypolipidemic agents BERLEX LAB (US) 1995-04-19 EP disclosed
US-4310359-A Pigment compositions TOYO INK MANUFACTURING CO., LTD. (JP) 1982-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170369424-A1 PREPARATION OF N,N-(DI)ALKYLAMINOALKYL(METH)ACRYLAMIDE OR N,N-(DI)ALKYLAMINOALKYL (METH)ACRYLATE AND THE QUATERNARY AMMONIUM SALTS THEREOF AS FLOCCULATING AIDS AND GELLING AGENTS REL, NAA15, ACMSD OPRM1 469/4885PLA2G1B 4302/4885PLA2G2A 4511/4885
US-10343980-B2 Preparation of N,N-(di)alkylaminoalkyl(meth)acrylamide or N,N-(di)alkylaminoalkyl (meth)acrylate and the quaternary ammonium salts thereof as flocculating aids and gelling agents REL, NAA15, ACMSD OPRM1 469/4885PLA2G1B 4302/4885PLA2G2A 4511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.